Mohamad A Morsey

USPTO Granted Patents = 32 (Patent Applications = 17)

CIPO Patents = 2 (Patent Applications = 15)

EPO Patents = 10 (Patent Applications = 24)

Average Co-Inventor Count = 3.1

ph-index = 5

Forward Citations = 110(Granted Patents)

Location History:

Niantic, CT (US) (2002 - 2012)
Elkhorn, NE (US) (2013 - 2014)
Omaha, NE (US) (2010 - 2023)

Company Filing History:

Metamorphix International, Inc.

patent

5. 1 out of 523

Pharmacia & Upjohn Company

patents

6. 1 out of 30

Schering-plough Animal Health Corporation

patents

7. 1 out of 104

Intervet International B.v.

patents

where one patent can have more than one assignee

Years Active: 2002-2025

Loading Chart...

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12435143 - Caninized antibodies against canine CTLA-4 (2025-10-07),

2. 12252536 - Caninized antibodies (2025-03-18),

3. 12239704 - Recombinant non-pathogenic Marek's disease virus constructs encoding multiple heterologous antigens (2025-03-04),

4. 12221486 - Caninized human antibodies to human IL-4R alpha (2025-02-11),

5. 12180288 - Antibodies to canine interleukin-4 receptor alpha (2024-12-31),

6. 11680097 - Antibodies against canine PD-1 (2023-06-20),

7. 11596687 - Recombinant non-pathogenic Marek's disease virus constructs encoding infectious laryngotracheitis virus and infectious bursal disease virus antigens (2023-03-07),

8. 11447561 - PD-L1 antibodies binding canine PD-L1 (2022-09-20),

9. 11248047 - Caninized antibodies (2022-02-15),

10. 11229698 - Recombinant non-pathogenic Marek's Disease virus constructs encoding multiple heterologous antigens (2022-01-25),

11. 11091556 - Caninized human antibodies to human IL-4R alpha (2021-08-17),

12. 10927172 - Caninized murine antibodies to human PD-1 (2021-02-23),

13. 10858437 - Antibodies to canine interleukin-4 receptor alpha (2020-12-08),

14. 10711061 - Antibodies against canine PD-1 (2020-07-14),

15. 10550194 - PD-L1 antibodies binding canine PD-L1 (2020-02-04),

Title: Innovator Spotlight: Mohamad A. Morsey from Elkhorn, NE

Introduction:

Mohamad A. Morsey, a prolific inventor based in Elkhorn, NE, has made significant contributions in the field of veterinary medicine with a total of 20 patents to his name. His innovative work has positively impacted the treatment of cancer in dogs and the development of novel poultry vaccines.

Latest Patents:

1. Antibodies against canine PD-1: Mohamad's groundbreaking invention involves antibodies to canine PD-1 with specific sequences and high binding affinity. These antibodies are utilized in the treatment of cancer in dogs, promising advancements in veterinary oncology.

2. Recombinant non-pathogenic Marek's disease virus constructs: Morsey's invention features recombinant multivalent non-pathogenic Marek's Disease virus constructs encoding Infectious Laryngotracheitis Virus and Infectious Bursal Disease virus antigens. These constructs are pivotal in the production of innovative poultry vaccines.

Career Highlights:

Throughout his career, Mohamad A. Morsey has worked with renowned companies in the animal health sector. Notably, he has contributed his expertise to Intervet Inc. and Schering-Plough Animal Health Corporation, demonstrating his commitment to advancing veterinary pharmaceuticals.

Collaborations:

Morsey has collaborated with esteemed professionals in his field, including Yuanzheng Zhang and Ian Tarpey. These partnerships have led to the successful development and implementation of cutting-edge technologies in veterinary medicine.

Conclusion:

In conclusion, Mohamad A. Morsey's remarkable inventions reflect his dedication to revolutionizing veterinary healthcare. His pioneering work in veterinary oncology and vaccine development underscores his status as a prominent innovator in the industry.

This text is generated by artificial intelligence and may not be accurate.